Screening tests are only one part of effective cancer screening programs. Real-world impact also depends on how screening is delivered and supported. Patients need clear information, practical access, and support through recommended follow-up. Care teams need timely data and workflows…
Oncology
St. Louis-based WashU Medicine investigators received an $11.7 million NIH grant to study the role of inflammation in myeloproliferative neoplasms, a group of blood cancers. The grant from the National Heart, Lung, and Blood Institute will support four major research…
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center broke ground Sept. 9 on its expanded Broadview Community Outreach and Engagement Center, which opened in 2023. The center works to address cancer disparities and improve outcomes by providing cancer prevention and screening…
Park Ridge, Ill.-based Advocate Lutheran General Hospital broke ground on its $99 million comprehensive cancer center Sept. 30. The 77,000-square-foot facility will house medical and surgical oncology, hematology, transplant and cellular therapy, 73 infusion treatment bays, survivorship services, a dedicated…
Siemens Healthineers debuted the Accela radiotherapy system Sept. 27 at the American Society for Radiation Oncology’s annual meeting in Boston. The system — which is pending FDA clearance — can deliver stereotactic body radiation therapy to multiple sites in about…
Advertisement
A cancer trend moving in the wrong direction Colorectal cancer (CRC) screening isn’t only a clinical priority for health systems; it’s also tied directly to capacity planning, quality performance, and cost of care. Colorectal cancer is widely recognized as one…
McKesson said unauthorized access and data exfiltration tied to a cybersecurity incident was limited to certain third-party applications affecting a subset of customers within its Oncology & Multispecialty business. The company said in a Sept. 21 update that the incident…
An FDA advisory panel will meet Sept. 23 to review GRAIL’s Galleri test, a blood-based screening tool for multiple cancer types that would be the first FDA-authorized multi-cancer early detection device if approved, according to the agency’s executive summary released…
CVS Health’s Aetna is expanding prior authorization bundles for cancer, available to some Medicaid members as of Sept. 1. The update impacts Medicaid members with providers in Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky and West Virginia who use…
Using mismatched donors for blood or bone marrow transplants is safe and could potentially lead to cures for blood cancers, Vanderbilt Health researchers found. The study, published in JAMA Network Open, compared nearly 670 patients across three studies: ACCESS trial…